Company Filing History:
1 out of 1,714 
1 out of 25 
1 out of 12 Years Active: 2017
Title: Takashi Angata: Innovator in Hepatic Disease Detection
Introduction
Takashi Angata is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of hepatic diseases. His innovative work focuses on the development of glycan markers that can effectively measure the disease state of hepatic conditions.
Latest Patents
Takashi Angata holds a patent for "Glycan markers as measure of disease state of hepatic diseases." This invention is aimed at developing glycan markers capable of detecting hepatic diseases, specifically those indicating the state of such diseases. The invention also seeks to create markers that can distinguish between different hepatic disease states, including the progression of hepatocarcinoma. The research identifies specific glycopeptides and glycoproteins whose glycan structures change due to hepatic diseases, providing novel markers for these conditions.
Career Highlights
Throughout his career, Takashi Angata has worked with esteemed institutions such as the National Institute of Advanced Industrial Science and Technology and Nagoya City University. His work has been pivotal in advancing the understanding and detection of hepatic diseases, contributing to better diagnostic methods.
Collaborations
Takashi Angata has collaborated with notable colleagues, including Hisashi Narimatsu and Jun Hirabayashi. Their combined expertise has furthered research in the field of glycan markers and hepatic disease detection.
Conclusion
Takashi Angata's innovative contributions to the detection of hepatic diseases through glycan markers highlight his importance in the medical research community. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in hepatic disease diagnosis.